SFRP1, a WNT pathway member, has been shown to be methylated and downregulated in the TCGA RCC cohort, including within the TCGA CIMP tumors, and has been associated with poorer outcome in ccRCC [33, 41–43]. Here, SFRP1 is linked to renal cell carcinoma.